Bovine Mesenteric Venous Graft as an Alternative Conduit in Patients with Cyanotic Heart Disease with E-Polytetrafluoroethylene Graft Failure Caused by Thrombophilic Factor Positivity after Modified Blalock-Taussig Shunt

2008 ◽  
Vol 11 (1) ◽  
pp. E37-E41
Author(s):  
B. Akbulut ◽  
Omer Faruk Dogan ◽  
M. Guvener ◽  
M. Yilmaz ◽  
C. Yorgancioglu ◽  
...  
1997 ◽  
Vol 7 (2) ◽  
pp. 153-159
Author(s):  
François Godart ◽  
Shakeel A. Qureshi ◽  
Ary Simha ◽  
Nuala Fagg ◽  
Philip B. Deverall ◽  
...  

AbstractConstruction of a modified Blalock-Taussig shunt using polytetrafluroethylene is frequently used for palliation in infants with complex cyanotic heart disease. This study was performed to assess angiographically the late patency rate of such prosthetic shunts. A modified Blalock-Taussig shunt had been constructed in 82 children and, of these, 63 (77%) patients had post-operative angiography and were included in this study. There were 29 males and 34 females, ranging in age from 1 day to 164 months. A second shunt was needed in 7 patients. Thus, 70 shunts were studied. Of the shunts, 16 were 4 mm in diameter, 28 shunts 5 mm in diameter, and 26 shunts 6 mm in diameter. Postoperative angiography was performed on 1 day to 132 months (median 39 months) after construction of the shunts. Acute post operative occlusion occurred in 2(3%) patients, who had 5 and 6 mm shunts, respectively. At the latest follow-up (median 39 ± 26 months), 6(9%) late occlusions were noticed. Overall patency was 89% for all the shunts, with 94% of the 4 mm shunts, 85% of the 5 mm and 88% of the 6 mm shunts being patent. Regression analysis showed a progressive reduction in diameter of the graft with time. This narrowing of the graft may have been related to the formation of a ‘neointima’ due to fibrous hyperplasia.


2013 ◽  
Vol 18 (2) ◽  
pp. 25
Author(s):  
DCL De Silva ◽  
SN Perera ◽  
I Wijemanne ◽  
LAP Perera ◽  
R Mahalekamge ◽  
...  

2021 ◽  
Vol 77 (18) ◽  
pp. 2975
Author(s):  
Amanda Meredith ◽  
Giselle Suero-Abreu ◽  
Renjit Thomas

2021 ◽  
pp. 1-5
Author(s):  
David E Saudek ◽  
Deborah Walbergh ◽  
Peter Bartz ◽  
Sara Shreve ◽  
Amy Schaal ◽  
...  

Abstract Background: Intranasal dexmedetomidine is an attractive option for procedural sedation in pediatrics due to ease of administration and its relatively short half-life. This study sought to compare the safety and efficacy of intranasal dexmedetomidine to a historical cohort of pediatric patients sedated using chloral hydrate in a pediatric echo lab. Methods: Chart review was performed to compare patients sedated between September, 2017 and October, 2019 using chloral hydrate and intranasal dexmedetomidine. Vital signs, time to sedation, duration of sedation, need for second dose of medication, rate of failed sedation, and impact on vital signs were compared between groups. Subgroup analysis was performed for those with complex and cyanotic heart disease. Results: Chloral hydrate was used in 356 patients and intranasal dexmedetomidine in 376. Patient age, complexity of heart disease, and duration of sedation were similar. Rates of failed sedation were very low and similar. Average heart rate and minimum heart rate were lower for those receiving intranasal dexmedetomidine than chloral hydrate. Impact on vital signs was similar for those with complex and cyanotic heart disease. No adverse events occurred in either group. Conclusions: Sedation with intranasal dexmedetomidine is comparable to chloral hydrate in regards to safety and efficacy for children requiring echocardiography. Consistent with the mechanism of action, patients receiving intranasal dexmedetomidine have a lower heart rate without morbidity.


2021 ◽  
pp. 1-5
Author(s):  
Bhanu Jayanand Sudhir ◽  
Sanjay Honavalli Murali ◽  
Jaypalsinh Gohil ◽  
Rajalakshmi Poyuran ◽  
Manikantan Sethuraman ◽  
...  

Noninfectious cerebral aneurysms are rare in patients with congenital cyanotic heart disease. We present a patient with DiGeorge/velocardiofacial syndrome with a complex congenital cyanotic heart disease with a ruptured anterior communicating artery aneurysm. The 10-year-old child was managed by surgical clipping of the aneurysm. Surgical challenges included prominent veins in the Sylvian fissure, difficulty in differentiating arterial and venous bleed, and anesthetic risks. The patient recovered without any neurological deficits. This is the first report of a patient with 22q11.2 deletion syndrome, with a noninfectious cerebral aneurysm.


2020 ◽  
Vol 4 (1) ◽  
Author(s):  
S. Madsen ◽  
L. P. Tolbod ◽  
U. M. Mortensen ◽  
G. Andersen ◽  
K. Bouchelouche

1993 ◽  
Vol 28 (2) ◽  
pp. 179-182 ◽  
Author(s):  
Yunus S. Loya ◽  
Robin J. Pinto ◽  
Dhruman M. Desai ◽  
Usha Sundaram ◽  
Ajit R. Bhagwat ◽  
...  

2017 ◽  
Vol 13 (1) ◽  
pp. 118-123 ◽  
Author(s):  
Randa M. Matter ◽  
Iman A. Ragab ◽  
Alaa M. Roushdy ◽  
Ahmed G. Ahmed ◽  
Hanan H. Aly ◽  
...  

2019 ◽  
Vol 105 (3) ◽  
pp. 142-146 ◽  
Author(s):  
Steven McVea ◽  
Anne McGettrick

Univentricular heart disease accounts for ~1.25% of all congenital heart disease. Such cases remain among the most challenging to manage, typically requiring a three-staged palliation. The first stage involves placement of a systemic to pulmonary shunt. While a variety of shunt types, including ductal stenting, can be used to manage univentricular conditions, the archetype remains the Blalock-Taussig (BT) shunt. While waiting future palliative intervention at home, intercurrent illness may necessitate presentation to a district general hospital where subspecialist advice and assessment is remote. This review aims to present the general paediatrician with a straightforward BT shunt physiology overview highlighting unique complications which may complicate intercurrent illness.


Sign in / Sign up

Export Citation Format

Share Document